Live updates: Pfizer and Moderna vaccines have reduced effectiveness against South African variant, new studies show - The Washington Post

The new findings add to wider concerns about the South African variant, which recently showed significant resistance to the vaccine developed by AstraZeneca and Oxford University in a small-scale trial.

Those results spurred South Africa’s government to scrap the vaccine in favor of the single-dose shot produced by Johnson & Johnson.